Comments
Loading...
Cellectis (CLLS) Forecast
NewsEarningsCellectis (CLLS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Cellectis Stock Price, Quotes and Forecasts | NASDAQ:CLLS | Benzinga
Explore Cellectis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLLS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ:CLLS) through any online brokerage.
Who are Cellectis (CLLS) competitors?
Other companies in Cellectis’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Korro Bio (NASDAQ:KRRO).
What is the forecast, or price target, for Cellectis (CLLS) stock?
Cellectis has a consensus price target of $7.80.
What is the current price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $1.46 last updated April 14, 2025 at 12:05 PM EDT.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q1 earnings are confirmed for Tuesday, May 27, 2025.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.